180 related articles for article (PubMed ID: 12676648)
1. Mechanisms of the free fatty acid-induced increase in hepatic glucose production.
Lam TK; Carpentier A; Lewis GF; van de Werve G; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E863-73. PubMed ID: 12676648
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent effects of fatty acids on skeletal muscle metabolism.
Hirabara SM; Silveira LR; Abdulkader F; Carvalho CR; Procopio J; Curi R
J Cell Physiol; 2007 Jan; 210(1):7-15. PubMed ID: 17013887
[TBL] [Abstract][Full Text] [Related]
3. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
4. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
5. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
Yoshii H; Lam TK; Gupta N; Goh T; Haber CA; Uchino H; Kim TT; Chong VZ; Shah K; Fantus IG; Mari A; Kawamori R; Giacca A
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
7. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
Boden G
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
[TBL] [Abstract][Full Text] [Related]
8. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile.
van Kempen AA; van der Crabben SN; Ackermans MT; Endert E; Kok JH; Sauerwein HP
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E723-30. PubMed ID: 16291574
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.
Kim SP; Catalano KJ; Hsu IR; Chiu JD; Richey JM; Bergman RN
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1590-8. PubMed ID: 17264230
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids and skeletal muscle insulin resistance.
Kraegen EW; Cooney GJ
Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
[TBL] [Abstract][Full Text] [Related]
13. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
Hirabara SM; Curi R; Maechler P
J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
[TBL] [Abstract][Full Text] [Related]
14. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
[TBL] [Abstract][Full Text] [Related]
15. Interdependence of hepatic lipid and glucose metabolism: novel pharmacological targets for diabetes.
Lind P
Curr Opin Investig Drugs; 2004 Apr; 5(4):395-401. PubMed ID: 15134280
[TBL] [Abstract][Full Text] [Related]
16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
17. Obesity, insulin resistance and hepatic perfusion.
Brock RW; Dorman RB
Microcirculation; 2007; 14(4-5):339-47. PubMed ID: 17613806
[TBL] [Abstract][Full Text] [Related]
18. Free fatty acids and insulin resistance.
Delarue J; Magnan C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
[TBL] [Abstract][Full Text] [Related]
19. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
20. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
